Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

[Infantile obesity: clinical and social aspects (author's transl)].

Rigon F, Pinello L, Pavan A, Monciotti C, Zancan L.

Pediatr Med Chir. 1981 Nov-Dec;3(6):541-4. Italian. No abstract available.

PMID:
7343952
2.

A clinical trial of fenfluramine in obese children.

Bacon GE, Lowrey GH.

Curr Ther Res Clin Exp. 1967 Dec;9(12):626-30. No abstract available.

PMID:
4965459
3.

Fenfluramine in the treatment of obesity.

Kneebone GM.

Med J Aust. 1968 Nov 9;2(19):833-5. No abstract available.

PMID:
5728209
4.

[Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].

Liebermeister H, Probst G, Jahnke K.

Med Klin. 1969;64(26):1201-7. German. No abstract available.

PMID:
5807324
5.

Fenfluramine in the treatment of obesity.

Spence AW, Medvei VC.

Br J Clin Pract. 1966 Dec;20(12):643-4. No abstract available.

PMID:
5974503
6.

[Results of treatment of obesity with low calorie diet and additional drugs (author's transl)].

Komarnicka R, Gorzko M.

Przegl Lek. 1975;32(11):814-7. Polish. No abstract available.

PMID:
1215566
7.

[Drug therapy of obesity].

Cairella M.

Clin Ter. 1978 Mar 31;84(6):571-92. Italian. No abstract available.

PMID:
648107
8.

A clinical trial of fenfluramine.

Traherne JB.

Practitioner. 1965 Nov;195(169):677-80. No abstract available.

PMID:
5321366
9.

Appetite suppressants for obesity.

Budenholzer B.

J Fam Pract. 1997 Jan;44(1):19-20. No abstract available.

PMID:
9010359
10.

Treatment of refractory obesity with fenfluramine.

Munro JF, Seaton DA, Duncan LJ.

Br Med J. 1966 Sep 10;2(5514):624-5. No abstract available.

11.

Management of obesity in Prader-Willi syndrome.

Butler MG.

Nat Clin Pract Endocrinol Metab. 2006 Nov;2(11):592-3. No abstract available.

PMID:
17082801
12.

A treatment for refractory obesity using fenfluramine without dietary restriction.

Sedgwick JP.

Br J Clin Pract. 1970 Jun;24(6):251-2. No abstract available.

PMID:
5456744
13.

[Current aspects and treatment of nutritional obesity in childhood].

Fleta Zaragozano J, Adán Pérez M.

An Esp Pediatr. 1990 Oct;33 Suppl 41:55-61. Spanish. No abstract available.

PMID:
2278462
14.

New agent for obesity management.

Barkin RL.

J Fam Pract. 1996 Sep;43(3):224. No abstract available.

PMID:
8797740
15.

Hypotensive effect of fenfluramine in the treatment of obesity.

[No authors listed]

Practitioner. 1971 Jul;207(237):101-5. No abstract available.

PMID:
5557039
16.
17.

New agent for obesity management.

Clemenson ND.

J Fam Pract. 1996 Sep;43(3):224; author reply 225. No abstract available.

PMID:
8797741
18.

Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity.

Anchors M.

Arch Intern Med. 1997 Jun 9;157(11):1270. No abstract available.

PMID:
9183245
19.

Drug to treat obesity: editorial writer responds.

Faich GA.

CMAJ. 1997 Apr 1;156(7):978. No abstract available.

20.

Iowa patients want new anti-obesity drug.

Belling W.

Iowa Med. 1996 Sep;86(7):278-9.

PMID:
8854575
Items per page

Supplemental Content

Support Center